Purple Biotech Ltd. logo
Purple Biotech Ltd. PPBT
$ 2.47 -4.26%

Annual report 2021
added 11-09-2024

report update icon

Purple Biotech Ltd. Balance Sheet 2011-2024 | PPBT

Annual Balance Sheet Purple Biotech Ltd.

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

- - - - - -6.76 M -10.6 M -1.31 M -193 K - -

Long Term Debt

- - - - - - - - - - -

Long Term Debt Current

199 K 207 K 195 K - - - - - - - -

Total Non Current Liabilities

- 953 K 313 K 405 K 1.52 M 256 K 185 K - - - -

Total Current Liabilities

- - - - - - - - - - -

Total Liabilities

- 4.05 M 3.86 M 3.72 M 5.59 M 1.53 M 1.38 M 986 K 1.26 M - -

Deferred Revenue

- - 961 K - 95 K - - - - - -

Retained Earnings

- -77.5 M -49.5 M -43.7 M -38.6 M -26.2 M -14.1 M -9.85 M -4.6 M - -

Total Assets

70.2 M 83.8 M 14.7 M 14.7 M 14.2 M 14.9 M 10.8 M 1.76 M 311 K - -

Cash and Cash Equivalents

10.9 M 11.2 M 4.38 M 5.16 M 3.95 M 6.76 M 10.6 M - - - -

Book Value

70.2 M 79.8 M 10.9 M 11 M 8.59 M 13.4 M 9.43 M 773 K -946 K - -

Total Shareholders Equity

- 79.8 M 10.9 M 11 M 8.69 M 13.4 M 9.43 M 773 K - - -

All numbers in USD currency

Quarterly Balance Sheet Purple Biotech Ltd.

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

- - - - 550 K - - - 688 K - - - 28 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - 842 K - - - 953 K - - - 313 K - 388 K - 405 K - 470 K - 1.52 M - - - 256 K - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

- - - - -95.9 M - - - -77.5 M - - - -49.5 M - -46.2 M - -43.7 M - -43.3 M - -38.5 M - - - -26.2 M - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

- - - - 70.2 M - - - 83.8 M - - - 14.7 M - 17.2 M - 14.7 M - 18.4 M - 14.2 M - - - 14.9 M - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

- - - - 10.9 M - - - 11.2 M - - - 4.38 M - 2.76 M - 5.16 M - 5.36 M - 3.95 M - 527 K - 6.76 M - - - 10.6 M - - - 1.31 M - - - - - - - - - - - - - - -

Book Value

- - - - 70.2 M - - - 83.8 M - - - 14.7 M - 17.2 M - 14.7 M - 18.4 M - 14.2 M - - - 14.9 M - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

- - - - 65.1 M - - - 79.8 M - - - 10.9 M - 11.4 M - 11 M - 10.7 M - 8.69 M - 12.5 M - 13.4 M - - - 9.43 M - - - 773 K - - - - - - - - - - - - - - -

All numbers in USD currency